Literature DB >> 8861993

Large trials vs meta-analysis of smaller trials: how do their results compare?

J C Cappelleri1, J P Ioannidis, C H Schmid, S D de Ferranti, M Aubert, T C Chalmers, J Lau.   

Abstract

OBJECTIVE: To evaluate the results of large clinical trials vs the pooled results of smaller trials. DATA IDENTIFICATION: Meta-analyses with at least 1 "large" study were identified from the Cochrane Pregnancy and Childbirth Database and from MEDLINE (1966-1995). STUDY SELECTION: We used a sample size approach to select 79 meta-analyses with at least 1 large study of 1000 or more patients. We used a statistical power approach to select 61 meta-analyses with at least 1 large study based on statistical power considerations. DATA EXTRACTION: The outcome of interest for each meta-analysis was the primary one stated in the original publication or, when not clearly specified, was decided on clinically. DATA SYNTHESIS: By random effects calculations, we found agreement between large and smaller trials in 90% of the meta-analyses selected by the sample size approach and in 82% of the meta-analyses selected by the statistical power approach. Twice as many disagreements appeared when the variability among large studies and among smaller studies was not considered (ie, fixed effects calculations). Of the 15 disagreements between results of large and smaller trials using the random effects model, plausible explanations were identified in 10 meta-analyses: 5 with differences in the control rate of events between large and smaller trials, 4 with specific protocol or study differences, and 1 with potential publication bias. Two other disagreements were not clinically important, and tentative reasons could be identified for 2 of the remaining 3 disagreements.
CONCLUSIONS: Results of smaller studies are usually compatible with the results of large studies, but discrepancies do occur even when the diversity among both large studies and smaller studies is considered. Clinically important differences without a potential explanation are extremely uncommon. Future research should further examine sources of heterogeneity between the results of large and smaller trials.

Entities:  

Mesh:

Year:  1996        PMID: 8861993

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  46 in total

1.  Converted laparoscopic colorectal surgery.

Authors:  P Gervaz; A Pikarsky; M Utech; M Secic; J Efron; B Belin; A Jain; S Wexner
Journal:  Surg Endosc       Date:  2001-05-11       Impact factor: 4.584

Review 2.  The use of meta-analysis in cost-effectiveness analysis. Issues and recommendations.

Authors:  S Saint; D L Veenstra; S D Sullivan
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

3.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.

Authors:  Fujian Song; Douglas G Altman; Anne-Marie Glenny; Jonathan J Deeks
Journal:  BMJ       Date:  2003-03-01

4.  Consistency of genome-wide associations across major ancestral groups.

Authors:  Evangelia E Ntzani; George Liberopoulos; Teri A Manolio; John P A Ioannidis
Journal:  Hum Genet       Date:  2011-12-20       Impact factor: 4.132

5.  The challenges of evidence-based medicine: a philosophical perspective.

Authors:  Abhaya V Kulkarni
Journal:  Med Health Care Philos       Date:  2005

6.  Why industry should register and disclose results of clinical studies--perspective of a recovering academic.

Authors:  Jesse A Berlin
Journal:  BMJ       Date:  2005-04-23

7.  Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Authors:  Panagiotis N Papanikolaou; Georgia D Christidi; John P A Ioannidis
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

8.  Large multicenter trials: what do they achieve and what should be done in perfusion?

Authors:  Paul Myles
Journal:  J Extra Corpor Technol       Date:  2007-12

9.  Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.

Authors:  David M Kent; Thomas A Trikalinos
Journal:  Am Heart J       Date:  2008-01-18       Impact factor: 4.749

Review 10.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Authors:  Marissa M Alejandria; Mary Ann D Lansang; Leonila F Dans; Jacinto Blas Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.